{"id":"W3112986797","doi":"10.1007/s40264-020-01008-0","title":"Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations","year":2020,"lang":"en","type":"review","venue":"Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Pharmacovigilance; Legislation; Medicine; Scope (computer science); Benchmarking; European union; Obligation; Business; Marketing authorization; Risk analysis (engineering); Pharmacology; Marketing; International trade; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1734497,0.003188865,0.004083766,0.009538739,0.002638804,0.01414469,0.01586989,0.0293297,0.01617096],"category_scores_gemma":[0.1722909,0.001848943,0.009892668,0.006845651,0.004887796,0.01293988,0.01342975,0.02032959,0.01337052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01368335,"about_ca_system_score_gemma":0.08325591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01383579,"about_ca_topic_score_gemma":0.007888345,"domain_scores_codex":[0.9149339,0.0443588,0.01238851,0.003746893,0.01922297,0.005348804],"domain_scores_gemma":[0.8409117,0.06442265,0.01115251,0.007322784,0.06267325,0.01351708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002503612,0.000677577,0.00114904,0.0117962,0.0004378742,0.0006324798,0.001052604,0.004728996,0.0007475779,0.07855177,0.410015,0.4899605],"study_design_scores_gemma":[0.0003200649,0.000260977,0.001420684,0.07081811,0.0005447922,0.0006287961,0.0006745811,0.002637084,0.0008081316,0.0862838,0.835502,0.0001010088],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001132486,0.1188279,0.07229249,0.7585635,0.0100417,0.002984329,0.001906452,0.001840635,0.03241056],"genre_scores_gemma":[0.02552811,0.2011186,0.4351967,0.2887428,0.008011922,0.01049079,0.01307859,0.0009547392,0.01687776],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.1734497,"threshold_uncertainty_score":0.9173006,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1345349921506546,"score_gpt":0.4755382153208398,"score_spread":0.3410032231701852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}